SequelSEC

GE HealthCare Technologies Inc. GEHC

X-Ray Apparatus & Tubes & Related Irradiation Apparatus · CIK 0001932393 · Fiscal year ends 1231

Revenue
$20.98B
Fiscal year ended 2026-03-31
Operating income
$2.65B
Fiscal year ended 2026-03-31
Free cash flow
Unavailable
Fiscal year ended 2026-03-31

GE HealthCare Technologies Inc. (GEHC) reported revenue of $20.98B and net income of $1.91B for the fiscal year ended 2026-03-31. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from GE HealthCare Technologies Inc.’s SEC filings, each linked to the filing it came from.

Income

GE HealthCare Technologies Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-03-31
Revenue$20.98B
Cost of revenueUnavailable
Gross profit$8.21B
Operating income$2.65B
Net income$1.91B
Research & development$1.26B
Weighted-average diluted sharesUnavailable
Pretax income$2.58B
Income tax expense$605.00M
Diluted EPSUnavailable
Selling, general & administrative$4.30B
General & administrativeUnavailable
Selling & marketingUnavailable

Balance

GE HealthCare Technologies Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-03-31
Cash & equivalents$2.26B
Total assets$37.12B
Current assets$10.43B
Total liabilities$26.23B
Current liabilities$8.53B
Total equity incl. NCI$10.68B
Temporary (mezzanine) equity$218.00M
Inventory$2.35B
Accounts receivableUnavailable
Goodwill$15.06B
Long-term debt$10.13B
Accounts payable$3.41B

Cash flow

GE HealthCare Technologies Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-03-31
Operating cash flowUnavailable
Capital expendituresUnavailable
Investing cash flow-$3.14B
Financing cash flow$924.00M
Net change in cash-$188.00M
Stock-based compensation$143.00M
Common dividends paid$64.00M
Common share repurchases$300.00M
Depreciation & amortizationUnavailable

Derived

GE HealthCare Technologies Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-03-31
Free cash flowUnavailable
Gross margin39.1%
Operating margin12.6%
FCF marginUnavailable
SBC / revenue0.7%
Current ratio1.22x
Revenue YoY growth6.0%
Net margin9.1%
R&D / revenue6.0%
CapEx / revenueUnavailable
Long-term debt / equity0.95x
Effective tax rate23.4%

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open GEHC in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-04-29View SEC filing
10-K · Filed 2026-02-04View SEC filing
10-Q · Filed 2025-10-29View SEC filing
10-Q · Filed 2025-07-30View SEC filing
10-Q · Filed 2025-04-30View SEC filing
10-K · Filed 2025-02-13View SEC filing

Companies in the same industry

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.